Daavlin Partners with HealthLens

HRS Scientific Sessions: Boston Scientific LBCT

During the Heart Rhythm Scientific Sessions this week, Boston Scientific announced positive LBCT data underscoring the safety and efficacy of multi-site pacing (MSP) over conventional cardiac resynchronization therapy (CRT), as well as poster presentations on real-world use of the WATCHMAN Left Atrial Appendage Closure (LAAC) device and next-generation WATCHMAN FLX LAAC device as alternatives to oral anticoagulation therapy for stroke risk reduction in patients with non-valvular atrial fibrillation.

What are the Most Commonly Performed Surgeries?

Whether you are trying to learn more about a surgery you are planning to have or find out what the most common procedures are, this list is here for you. Read more.

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

Daavlin is a leading U.S. manufacturer of phototherapy units that use therapeutic ultraviolet light to safely and effectively treat patients with psoriasis, vitiligo, and eczema.  “Although many patients begin treatment in a clinical setting, an increasing number of patients prefer to treat in the privacy of their homes,” says CEO, David Swanson.  “Our partnership with HealthLens and the creation of DaavlinDirect is giving better access to patients who can receive both a dermatology consultation and their treatment from the comfort of home.”

In a recent study conducted by Hanover Research of over 400 psoriasis patients, nearly 90% reported that their condition had a moderate to major negative impact on their quality of life.1 Traci Hartman, Vice President of Consumer Markets for Daavlin, says, “Psoriasis symptoms can be debilitating.  Many patients suffer from itching, scaling of the skin, burning and/or swelling.  These symptoms keep many people from doing the things they enjoy and can even impact daily activities that most of us take for granted.  Other dermatological diseases such as vitiligo and eczema can be equally burdensome.” And unfortunately, the length of time it takes to see a dermatologist has increased significantly over the last several years.

According to a report released by Greater Access for Patient Partners (GAPP), appointment wait times for dermatology services have increased by 46% since 2009.  The average wait time to receive a dermatology appointment is 32.3 days.  However, with a new partnership between Daavlin and HealthLens called DaavlinDirect, patients will be able to have their condition evaluated and begin treatment much more quickly.

DaavlinDirect connects board-certified physicians with patients through an online telemedicine portal powered by HealthLens.  Patients can easily secure an online consultation with a physician of their choice through a computer, smartphone or tablet.  After answering a brief health history and uploading a few photos of their skin condition, the information is electronically encrypted and securely sent to the selected physician.  The patient information is then reviewed and the physician typically responds within 1-2 business days.

If the physician determines that home phototherapy is the right treatment for the patient, a light therapy prescription is sent to Daavlin to fill.  Instead of waiting weeks to see a physician and start therapy, a patient could begin treatments much more quickly.  C.B., a patient from San Jose, California provided his opinion of the new service.  “At first, I was skeptical, but now I am so happy I tried DaavlinDirect. I was amazed that I could get an evaluation and prescription from a board-certified dermatologist in less than a day! And it was done all online.”

Patients in the states of California, Washington, New York, New Jersey, Connecticut, Florida, Mississippi, and Tennessee are currently able to use the service.  “We are very excited to launch DaavlinDirect in a few states now and look forward to adding coverage over the coming months,” adds Hartman.


1Hanover Research. September 2019. “Psoriasis Patients’ Path to Treatment.”



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.